BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 22805737)

  • 1. [How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].
    Drapkina OM; Korneeva ON
    Kardiologiia; 2012; 52(8):89-92. PubMed ID: 23098406
    [No Abstract]   [Full Text] [Related]  

  • 2. Into the wardrobe of Narnia: beyond HIV infection a world of cardiovascular risk.
    Colotto M; Renzi A; Durante C
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22805737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?
    de Lorgeril M
    World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary macroadenoma presenting with brow mass and acromegaly.
    Lee EW; Nelson ER; Harrison AR
    Ophthalmic Plast Reconstr Surg; 2009; 25(1):56-7. PubMed ID: 19273930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in a woman with acromegaly after transsphenoidal partial resection of pituitary macroadenoma - a case report.
    Tomczyk K; Rzymski P; Woźniak J; Wilczak M
    Pol Merkur Lekarski; 2017 Dec; 43(258):268-271. PubMed ID: 29298966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe.
    Yamazaki D; Ishida M; Watanabe H; Nobori K; Oguma Y; Terata Y; Koyama T; Iino K; Kosaka T; Ito H
    Lipids Health Dis; 2013 Feb; 12():9. PubMed ID: 23374898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
    Elis A; Zhou R; Stein EA
    Am J Cardiol; 2011 Jul; 108(2):223-6. PubMed ID: 21545982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.
    Bedimo R; Westfall AO; Mugavero M; Drechsler H; Khanna N; Saag M
    HIV Med; 2010 Aug; 11(7):462-8. PubMed ID: 20163481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular manifestations of HIV infection.
    Ho JE; Hsue PY
    Heart; 2009 Jul; 95(14):1193-202. PubMed ID: 19564432
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C virus infection and the risk of coronary disease.
    Butt AA; Xiaoqiang W; Budoff M; Leaf D; Kuller LH; Justice AC
    Clin Infect Dis; 2009 Jul; 49(2):225-32. PubMed ID: 19508169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical progress: Acromegaly.
    Melmed S
    N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
    [No Abstract]   [Full Text] [Related]  

  • 12. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia.
    Civeira F;
    Atherosclerosis; 2004 Mar; 173(1):55-68. PubMed ID: 15177124
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.